Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
QuintilesIMS
Baxter
Daiichi Sankyo
Deloitte
UBS
US Department of Justice
McKinsey
Covington
Moodys

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020135

« Back to Dashboard

NDA 020135 describes MOTRIN, which is a drug marketed by Mcneil, Mcneil Consumer, Mcneil Ped, and J And J Consumer Inc, and is included in six NDAs. Additional details are available on the MOTRIN profile page.

The generic ingredient in MOTRIN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-three suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for 020135

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, CHEWABLE;ORALStrength50MG
Approval Date:Nov 16, 1994TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, CHEWABLE;ORALStrength100MG
Approval Date:Nov 16, 1994TE:RLD:No

Expired Orange Book Patents for NDA: 020135

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-001Nov 16, 1994► Subscribe► Subscribe
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-002Nov 16, 1994► Subscribe► Subscribe
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-002Nov 16, 1994► Subscribe► Subscribe
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-001Nov 16, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Queensland Health
Cerilliant
Mallinckrodt
Harvard Business School
US Department of Justice
Medtronic
McKesson
Moodys
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot